Literature DB >> 1376371

Molecular basis of antigenic structures of poliovirus: implications for their evolution during morphogenesis.

K Wiegers1, R Dernick.   

Abstract

Neutralizing monoclonal antibodies against poliovirus type 1 were obtained after conventional immunization or combined in vivo-in vitro immunization. Antibody binding sites were determined by sequence analysis of neutralization-resistant mutants. Site 3 variants had several amino acid substitutions in previously unidentified positions for neutralization resistance. Evidence for a linkage of subsites 3a and 3b is presented. Some site 3b antibodies as defined previously precipitated 14S subunits, although with reduced titers.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1376371      PMCID： PMC241275     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  26 in total

1.  Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1.

Authors:  K J Wiegers; K Wetz; R Dernick
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

2.  Antigenic structure of polioviruses of serotypes 1, 2 and 3.

Authors:  P D Minor; M Ferguson; D M Evans; J W Almond; J P Icenogle
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

3.  A new antigenic site of poliovirus recognized by an intertypic cross-neutralizing monoclonal antibody.

Authors:  J Uhlig; K Wiegers; R Dernick
Journal:  Virology       Date:  1990-10       Impact factor: 3.616

4.  Three-dimensional structure of poliovirus serotype 1 neutralizing determinants.

Authors:  G S Page; A G Mosser; J M Hogle; D J Filman; R R Rueckert; M Chow
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

5.  Evidence for a complex structure of neutralization antigenic site I of poliovirus type 1 Mahoney.

Authors:  K Wiegers; H Uhlig; R Dernick
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

6.  A simple quantitative protein A micro-immunoprecipitation method; assay of antibodies to the N and H antigens of poliovirus.

Authors:  R Vrijsen; B Rombaut; A Boeyé
Journal:  J Immunol Methods       Date:  1983-04-29       Impact factor: 2.303

7.  Construction of a poliovirus type 1/type 2 antigenic hybrid by manipulation of neutralization antigenic site II.

Authors:  A D Murdin; E Wimmer
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  N-AgIB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 comprising residues 96-104 and 141-152.

Authors:  K Wiegers; H Uhlig; R Dernick
Journal:  Virology       Date:  1989-06       Impact factor: 3.616

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Antigenic variation and resistance to neutralization in poliovirus type 1.

Authors:  D C Diamond; B A Jameson; J Bonin; M Kohara; S Abe; H Itoh; T Komatsu; M Arita; S Kuge; A Nomoto
Journal:  Science       Date:  1985-09-13       Impact factor: 47.728
View more
  4 in total

1.  Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China.

Authors:  Dongmei Yan; Yong Zhang; Shuangli Zhu; Na Chen; Xiaolei Li; Dongyan Wang; Xiaozhen Ma; Hui Zhu; Wenbin Tong; Wenbo Xu
Journal:  Clin Vaccine Immunol       Date:  2014-05-21

2.  Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.

Authors:  Jing Shaw; Jaume Jorba; Kun Zhao; Jane Iber; Qi Chen; Festus Adu; Adekunle Adeniji; David Bukbuk; Marycelin Baba; Elizabeth Henderson; Naomi Dybdahl-Sissoko; Sharla McDonald; William C Weldon; Nicksy Gumede; M Steven Oberste; Olen M Kew; Cara C Burns
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

3.  Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell.

Authors:  T Couderc; J Hogle; H Le Blay; F Horaud; B Blondel
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

4.  An Insight into Recombination with Enterovirus Species C and Nucleotide G-480 Reversion from the Viewpoint of Neurovirulence of Vaccine-Derived Polioviruses.

Authors:  Yong Zhang; Dongmei Yan; Shuangli Zhu; Yorihiro Nishimura; Xufang Ye; Dongyan Wang; Jaume Jorba; Hui Zhu; Hongqiu An; Hiroyuki Shimizu; Olen Kew; Wenbo Xu
Journal:  Sci Rep       Date:  2015-11-25       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.